What is the ROE (Return on Equity) of Nevro this year?
The ROE of Nevro this year is -0.49 undefined.
Nevro ROE 2025
Nevro ROE
-0.49
Ticker
NVRO
ISIN
US64157F1030
WKN
A12EPL
In 2025, Nevro's return on equity (ROE) was -0.49, a 56.11% increase from the -0.31 ROE in the previous year.
Nevro Aktienanalyse
What does Nevro do?
Nevro Corp is a global leader in innovative medical products and therapy systems. The company was founded in 2006 and is headquartered in Redwood City, California. Nevro Corp is a pioneer in the development of novel implantable medical technologies and has brought a variety of products to the market since its founding, enabling revolutionary advances in pain therapy. Nevro Corp's business model is based on the production, marketing, and sale of implantable neuromodulation devices that can reduce or even eliminate chronic pain in patients. These devices are able to send electrical signals to individual nerve fibers to target and treat pain in specific areas of the body. With this innovative technology, Nevro Corp has revolutionized the pain therapy market and filled a niche that conventional treatment methods could not address. Nevro Corp has various divisions and branches worldwide. An important area of the company is research and development, where new and innovative pain therapy technologies are constantly being developed. Another division is marketing, where the company's products are sold to medical specialists, hospitals, and clinics worldwide. In addition, Nevro Corp also offers training and education to inform medical professionals about the company and its products. The products offered by Nevro Corp include implantable neuromodulation systems such as the Senza system and the HF10 system. The Senza system is a spinal cord stimulator that is controlled via a remote and sends electrical impulses to the spinal cord to relieve pain in the arms, legs, and back. The HF10 system works with high-frequency technology and was developed to treat chronic pain in the lower back. In addition to these products, Nevro Corp has also introduced a range of accessories and enhancements to facilitate the operation and maintenance of the implantable devices. These include, for example, wireless chargers or a special remote control that allows patients to individually adjust their therapy. In summary, Nevro Corp is an innovative and successful provider of medical products and therapy systems specializing in pain therapy. With sophisticated technology, state-of-the-art research and development, and a dedicated workforce, the company has made a significant contribution to improving the quality of life for millions of patients worldwide and will continue to develop innovative and effective therapies in the future. Nevro ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Nevro's Return on Equity (ROE)
Nevro's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Nevro's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Nevro's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Nevro’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Nevro stock
How has the Return on Equity (ROE) of Nevro developed compared to the previous year?
The ROE of Nevro has increased by 56.11% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Nevro?
A high ROE indicates that Nevro generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Nevro?
A low ROE can indicate that Nevro is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Nevro affect the company?
A change in ROE (Return on Equity) of Nevro can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Nevro?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Nevro?
Some factors that can influence Nevro's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Nevro pay?
Over the past 12 months, Nevro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nevro is expected to pay a dividend of 0 USD.
What is the dividend yield of Nevro?
The current dividend yield of Nevro is .
When does Nevro pay dividends?
Nevro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nevro?
Nevro paid dividends every year for the past 0 years.
What is the dividend of Nevro?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nevro located?
Nevro is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nevro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nevro from 4/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2025.
When did Nevro pay the last dividend?
The last dividend was paid out on 4/27/2025.
What was the dividend of Nevro in the year 2024?
In the year 2024, Nevro distributed 0 USD as dividends.
In which currency does Nevro pay out the dividend?
The dividends of Nevro are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nevro stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nevro
Our stock analysis for Nevro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nevro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
